There are lawsuits, legal settlements, recalls, executive firings, employee layoffs, few new drugs in the pipeline. The pharmaceutical industry is in trouble on many fronts. In this blog post, let's just look at one of the challenges: That's the blow to the industry's reputational capital. This is happening at a time when even the most conservative economists are conceding that at this stage of capitalism there's more to business than primarily maximizing shareholder value.
Discuss Add this link to...Bury Add to:
| Bookmarks
Comments